Medtronic Guides FY25 Adj. EPS In Line With Estimates; Boosts Dividend - Update

RTTNews | 412 days ago
Stocktwits
Medtronic Guides FY25 Adj. EPS In Line With Estimates; Boosts Dividend - Update

(RTTNews) - While reporting financial results for the fourth quarter on Thursday, medical devices maker Medtronic plc. (MDT) initiated its adjusted earnings, revenue growth and organic revenue growth guidance for the full-year 2025.

For fiscal 2025, the company now projects adjusted earnings in a range of $5.40 to $5.50 per share on revenue growth of 2.4 to 3.7 percent, with organic revenue growth of 4.0 to 5.0 percent.

On average, 32 analysts polled by Thomson Reuters expect the company to report earnings of $5.45 per share on revenue growth of 4.2 percent to $33.58 billion for the quarter. Analysts' estimates typically exclude special items.

On Wednesday, the Medtronic board of directors approved an increase in Medtronic's cash dividend for the first quarter of fiscal year 2025 to $0.70 per ordinary share, payable on July 12, 2024, to shareholders of record at the close of business on June 28, 2024.

The company said it remains committed to returning a minimum of 50% of its free cash flow to shareholders, primarily through dividends, and to a lesser extent, share repurchases.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Tags: MDT
Stocktwits
read more
FDA Upgrades Medtronic Recall Of Newport Ventilators To Class I

FDA Upgrades Medtronic Recall Of Newport Ventilators To Class I

Medical devices maker Medtronic plc has urged customers to discontinue clinical use of the recently recalled certain Newport branded ventilators and certain related service parts after the U.S. Food and Drug Administration upgraded it to a Class I recall. According to the FDA, a Class I recall is the most serious type of recall, a situation where the use of, or exposure to, a violative product...
RTTNews | 27 days ago
Medtronic Files Complaint Against Axonics With US ITC For Two Patent Infringements

Medtronic Files Complaint Against Axonics With US ITC For Two Patent Infringements

Healthcare technology company Medtronic plc (MDT) announced Thursday it filed a complaint with the U.S. International Trade Commission (ITC), along with a parallel action in U.S. District Court for the District of Delaware, to block Axonics, Inc. (AXNX) from improperly importing and selling products that infringe two Medtronic patents related to the MRI compatibility of implantable medical devices.
RTTNews | 496 days ago
Medtronic Boosts FY24 Outlook - Update

Medtronic Boosts FY24 Outlook - Update

While reporting financial results for the third quarter on Tuesday, medical devices maker Medtronic plc. (MDT) raised its adjusted earnings and organic revenue growth guidance for the full-year 2024, based on third quarter performance.
RTTNews | 505 days ago
Medtronic Boosts FY23 Adj. EPS Outlook - Update

Medtronic Boosts FY23 Adj. EPS Outlook - Update

While reporting financial results for the third quarter on Tuesday, medical devices maker Medtronic plc. (MDT) provided its revenue growth guidance for the fourth quarter and raised adjusted earnings outlook for the full-year 2023, based on third quarter performance.
RTTNews | 869 days ago
Medtronic Reiterates FY23 Outlook - Update

Medtronic Reiterates FY23 Outlook - Update

While reporting financial results for the first quarter on Tuesday, medical devices maker Medtronic plc. (MDT) reiterated its adjusted earnings and revenue growth guidance for the full-year 2023.
RTTNews | 1051 days ago
Tools
Economic Calendar
Market Hours
Interest Rates
Holidays Calendar
Forex Market
Forex Volatility
Forex Correlation
Forex News
forex analysis
COT Data
Liquidity
Forex Calculators
Forex Heat Map
Indicators Heatmap
Community
Community
Systems
Most Popular Systems
Strategies
Contests
Forex Charts
Forex Sentiment
Sentiment Indicator
Reviews
Brokers
Prop Trading Firms
VPS Services
Signal Providers
EA Programming Services
Affiliate Programs
PAMM Broker Services
Rebate Program Services
Trading Platforms
Expert Advisors
Crypto Exchanges
Trading Courses
Brokers
Forex Spreads
Forex Broker Quotes
Forex Broker Swaps
Forex Broker Volume
Forex Broker Promotions Press Release
Platform
Widgets
Features
API
RSS
Stock Portfolio
Affiliate Software
Advanced Charts
Support
FAQ
Help
Contact Us
Report a Bug!
About
Blog
© 2025 Myfxbook Ltd. All Rights Reserved.
HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.